“The race to find vaccines for COVID-19 has dominated the headlines,” runs the opening of a CBS News story, “but there’s been less news about how to keep people with COVID out of the hospital.”
Accurate, so far as it goes, but something is missing.
The story that follows is about an anti-depressant developed decades ago, and “a small but ingenious clinical trial and a series of coincidences [that] have led scientists to look closely at fluvoxamine as a possible tool to keep newly diagnosed COVID-19 patients from becoming severely ill.”
The drug, the story tells, may do what has been claimed for a number of treatments (vitamins, minerals, and the infamous hydroxychloroquine, or HCQ): that is, prevent patients from developing COVID’s severe, deadly respiratory distress.
Yet, in a time of crisis, discussion of such treatments were regarded as “fake news” by social media; doctors and researchers who discussed them online had their videos removed and their posts suppressed. Neil Cavuto and others raised alarms. But now the American Journal of Medicine recommends HCQ, along with “Azithromycin, and Zinc for the treatment of Covid 19 outpatients.”
So when CBS tells us that there has “been great caution about recommending repurposed drugs for COVID after the malaria drug hydroxychloroquine was promoted as a potential ‘game-changer’ by former President Trump — before it was tested in a large clinical trial on COVID patients,” let’s not forget what they are still hiding: that major media along with several governors and many “influencers” suppressed information about drugs that saved some lives and could have saved more.
All while seeking to eradicate the disease they feared most, Trump.
This is Common Sense. I’m Paul Jacob.
—
See all recent commentary
(simplified and organized)